Boundless Bio, Inc.

Boundless Bio, Inc.verified

BOLD

Price:

$1.41

Market Cap:

$31.67M

Boundless Bio, Inc., a clinical-stage oncology company, focuses on developing innovative cancer therapies aimed at addressing the significant unmet needs of patients with oncogene amplified tumors. Their core strategy involves targeting extrachromosomal DNA (ecDNA). The company's lead product candidate, BBI-355, an orally administered inhibitor of checkpoint kinase 1 (CHK1), is currently in Phase 1/2 clinical trials for patients suffering from oncogene amplified cancers. Additionally, Boundless Bio is advancing BBI-825, another oral inhibitor, this one targeting ribonucleotide reductase (RNR), also in Phase 1/2 clinical development for cancer patients exhibiting resistance gene amplification...[Read more]

Industry

Biotechnology

IPO Date

2016-07-20

Stock Exchange

NASDAQ

Ticker

BOLD

The ROE as of June 2026 (TTM) for Boundless Bio, Inc. (BOLD) is -53.60%

According to Boundless Bio, Inc.’s latest financial reports and current stock price. The company's current ROE is -53.60%. This represents a change of 296.08% compared to the average of -13.53% of the last 4 quarters.

Boundless Bio, Inc. (BOLD) Historical ROE (quarterly & annually)

How has BOLD ROE performed in the past?

The mean historical ROE of Boundless Bio, Inc. over the last ten years is -9.75%. The current -53.60% ROE has changed 449.79% with respect to the historical average. Over the past ten years (40 quarters), BOLD's ROE was at its highest in in the December 2022 quarter at 14.42%. The ROE was at its lowest in in the December 2017 quarter at -57.62%.

Quarterly (TTM)
Annual

Average

-9.75%

Median

-36.24%

Minimum

-58.99%

Maximum

66.01%

Boundless Bio, Inc. (BOLD) ROE by Quarter and Year

Discovering the peaks and valleys of Boundless Bio, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 35.96%

Maximum Annual ROE = 66.01%

Minimum Annual Increase = -326.89%

Minimum Annual ROE = -58.99%

Quarterly (TTM)
Annual
YearROEChange
2025-58.99%35.96%
2024-43.39%-211.54%
202338.90%-30.77%
202256.19%-14.89%
202166.01%-326.89%
2018-29.10%-49.51%
2017-57.62%15.28%

Boundless Bio, Inc. (BOLD) Average ROE

How has BOLD ROE performed in the past?

The current ROE of Boundless Bio, Inc. (BOLD) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

-21.16%

5-year avg

11.74%

10-year avg

-9.75%

Boundless Bio, Inc. (BOLD) ROE vs. Peers

How is BOLD’s ROE compared to its peers?

Boundless Bio, Inc.’s ROE is less than Q32 Bio Inc. (230.68%), greater than NextCure, Inc. (-186.96%), greater than Plus Therapeutics, Inc. (-198.48%), greater than Intensity Therapeutics, Inc. (-136.82%), less than Iterum Therapeutics plc (602.38%), greater than AN2 Therapeutics, Inc. (-52.35%), less than Pluri Inc. (203.55%), greater than Rallybio Corporation (-14.39%), greater than Sonnet BioTherapeutics Holdings, Inc. (-518.10%), greater than TAO Synergies Inc. (-120.29%),

Build a custom stock screener for Boundless Bio, Inc. (BOLD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Boundless Bio, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Boundless Bio, Inc. (BOLD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Boundless Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Boundless Bio, Inc.'s ROE?

How is the ROE calculated for Boundless Bio, Inc. (BOLD)?

What is the highest ROE for Boundless Bio, Inc. (BOLD)?

What is the 3-year average ROE for Boundless Bio, Inc. (BOLD)?

What is the 5-year average ROE for Boundless Bio, Inc. (BOLD)?

How does the current ROE for Boundless Bio, Inc. (BOLD) compare to its historical average?